Cy­to­ki­net­ics

Last updated: May 08, 2024

CEO Robert I. Blum
CEO Robert I. Blum
Country: USA | Funding: $1.2B (+)

Website: https://cytokinetics.com/

Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised.